Brief: Pelthos Therapeutics - On Dec 23, Enters Asset Purchase Agreement With Hatchtech - SEC Filing
02/01/2026 22:00
Jan 2 (Reuters) - Pelthos Therapeutics Inc PTHS.A: PELTHOS THERAPEUTICS INC - ON DEC 23, ENTERS ASSET PURCHASE AGREEMENT WITH HATCHTECH - SEC FILING PELTHOS THERAPEUTICS INC - HATCHTECH SELLS RIGHTS TO XEGLYZE PRODUCT TO CO FOR $1.8 MILLION - SEC FILING Source text: [ID:n0001753926-26-000010] Further company coverage: PTHS.A ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Pelthos Therapeutics
See all newsPelthos Therapeutics falls as co says will restate Q1 financial statements
Brief: Pelthos Therapeutics Financial Statements Should No Longer Be Relied Upon For Quarter Ended March 31- SEC Filing
Pelthos Therapeutics Q2 revenue rises on Zelsuvmi adoption
Brief: Pelthos Therapeutics Announces CFO Transition
Brief: Pelthos Therapeutics Announces First Patient Dosed In Phase 1B/2A Clinical Trial Of Ct2000 In Eye Pain